Versant Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $730 | Buy |
+15
| New | +$730 | ﹤0.01% | 2518 |
|
|
2025
Q1 | – | Sell |
-35
| Closed | -$1.38K | – | 2541 |
|
|
2024
Q4 | $1.38K | Hold |
35
| – | – | ﹤0.01% | 2129 |
|
|
2024
Q3 | $1.64K | Buy |
+35
| New | +$1.64K | ﹤0.01% | 1617 |
|
|
2023
Q3 | – | Sell |
-42
| Closed | -$2.36K | – | 1959 |
|
|
2023
Q2 | $2.36K | Buy |
+42
| New | +$2.36K | ﹤0.01% | 1313 |
|